Eli Lilly and Novo Nordisk to maintain 'two-horse race' in GLP-1 weight loss market
U.Ozel.Images/E+ via Getty Images Although other companies are on the cusp of gaining approval for GLP-1 receptor agonist weight-loss drugs, ...
U.Ozel.Images/E+ via Getty Images Although other companies are on the cusp of gaining approval for GLP-1 receptor agonist weight-loss drugs, ...
WendellandCarolyn/iStock Editorial via Getty Images Hooks (New York Stock Exchange:KR) has followed Costco Wholesale (NASDAQ:COST) by offering popular GLP-1 drugs ...
Katrina Wittkamp Food companies continue to target consumers taking weight loss medications with new options that may align with their ...
Svitlana Hulkó Users of GLP-1 drugs such as Ozempic, Wegovy and Zepbound are more likely to undergo cosmetic procedures, which ...
Rawpixel/iStock via Getty Images Lexaria Stock (NASDAQ:LEXX) rose 20% in morning trading Monday after the drug delivery company announced positive ...
Capuski/E+ via Getty Images The growing popularity of GLP-1 weight-loss drugs may be already impacting demand for certain procedures like ...